Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK1 | P06493 | 2/20 | 0.54 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.54 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.54 |
| ▸ | GSK3B | P49841 | 1/20 | 0.54 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.54 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.49 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.49 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.49 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.49 |
| ▸ | TSPO | P30536 | 2/20 | 0.48 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.46 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.46 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.46 |
| ▸ | NR1H2 | P55055 | 9/20 | 0.44 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.44 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.44 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | CNR2 | P34972 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29357718 | 1.00 | CDK1 (0.54) | CDK1CCNB2CCNB1GSK3BCCNB3 | |
| SCHEMBL409607 | 0.93 | CDK1 (0.54) | CDK1CCNB2CCNB1GSK3BCCNB3 | |
| SCHEMBL15456145 | 0.92 | CDK1 (0.49) | CDK1CCNB2CCNB1GSK3BCCNB3 | |
| SCHEMBL30022454 | 0.87 | CHRM2 (0.59) | CHRM2CHRM4CHRM1CHRM3GABRG2 | |
| SCHEMBL13696680 | 0.87 | CHRM2 (0.59) | CHRM2CHRM4CHRM1CHRM3GABRG2 | |
| SCHEMBL2186140 | 0.86 | CCNB2 (0.49) | CDK1CCNB2CCNB1GSK3BCCNB3 | |
| SCHEMBL15280123 | 0.84 | CHRM2 (0.50) | CDK1CCNB2CCNB1GSK3BCCNB3 | |
| SCHEMBL27985045 | 0.84 | CHRM2 (0.50) | CDK1CCNB2CCNB1GSK3BCCNB3 | |
| SCHEMBL6483062 | 0.83 | CHRM2 (0.49) | CDK1CCNB2CCNB1GSK3BCCNB3 | |
| SCHEMBL13932559 | 0.83 | CHRM2 (0.49) | CDK1CCNB2CCNB1GSK3BCCNB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230174485-A1 | LIPOXYGENASE INHIBITORS | SRI INTERNATIONAL (US) | 2023-06-08 | — | — | US | disclosed |
| US-20230174485-A1 | LIPOXYGENASE INHIBITORS | SRI INTERNATIONAL (US) | 2023-06-08 | — | — | US | disclosed |
| US-20230174485-A1 | LIPOXYGENASE INHIBITORS | SRI INTERNATIONAL (US) | 2023-06-08 | — | — | US | disclosed |
| CN-115335046-A | Lipoxygenase inhibitors | 思研（SRI）国际顾问与咨询公司 | 2022-11-11 | — | — | CN | disclosed |
| EP-3943492-A1 | TADF MATERIALS COMPRISING 4-(3-(2-(10H-PHENOXAZIN-10-YL)PYRIDIN-5-YL)-9H-CARBAZOL-9-YL)BENZONITRILE DERIVATIVES AND RELATED COMPOUNDS FOR USE IN OLEDS | Noctiluca S.A. (PL) | 2022-01-26 | — | — | EP | disclosed |
| WO-2021195346-A1 | LIPOXYGENASE INHIBITORS | SRI INTERNATIONAL (US) | 2021-09-30 | — | — | WO | disclosed |
| US-10351557-B2 | Compounds for electronic devices | MERCK PATENT GMBH (DE) | 2019-07-16 | — | — | US | disclosed |
| US-10319912-B2 | Charge-transporting material and organic light-emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-06-11 | — | — | US | disclosed |
| US-10270036-B2 | Polymer, composition including the polymer, and organic light-emitting device including the polymer | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-04-23 | — | — | US | disclosed |
| US-20180182967-A1 | POLYMER, COMPOSITION INCLUDING THE POLYMER, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE POLYMER | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2018-06-28 | — | — | US | disclosed |
| CN-102448946-B | Material for organic electroluminescent device | MERCK PATENT GMBH (DE) | 2015-10-21 | — | — | CN | disclosed |
| US-9126970-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2015-09-08 | — | — | US | disclosed |
| US-9126970-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2015-09-08 | — | — | US | disclosed |
| WO-2014021569-A1 | COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME | SK CHEMICALS CO., LTD. (KR) | 2014-02-06 | — | — | WO | disclosed |
| US-20130092879-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2013-04-18 | — | — | US | disclosed |
| US-20130092879-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2013-04-18 | — | — | US | disclosed |
| CN-102947304-A | Compounds for electronic devices | MERCK PATENT GMBH | 2013-02-27 | — | — | CN | disclosed |
| CN-102448946-A | Material for organic electroluminescent device | MERCK PATENT GMBH | 2012-05-09 | — | — | CN | disclosed |
| US-20120068170-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2012-03-22 | — | — | US | disclosed |
| US-20120068170-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2012-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230174485-A1 | LIPOXYGENASE INHIBITORS | ALOX15B, ALOX12, ALOX15 | CDK1 2283/4885CCNB2 1919/4885CCNB1 1903/4885 |
| US-10351557-B2 | Compounds for electronic devices | CYP1B1, CYP2C19, CYP1A1 | CDK1 1083/4885CCNB2 1129/4885CCNB1 1112/4885 |
| US-20120068170-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | SLCO2B1, SLCO1B3, SLCO4C1 | CDK1 2210/4885CCNB2 1080/4885CCNB1 1009/4885 |
| US-20130092879-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | CYP1B1, CYP2C19, CYP1A1 | CDK1 1083/4885CCNB2 1093/4885CCNB1 1096/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.